Faculty of oral and dental medicine
Cairo, Egypt
NCT Number: NCT02160613
The study hypothesis:
Is Osteoprotegerin a diagnostic and/or prognostic marker of periodontal disease?
Looking for future studies?
Notify Me32 year–55 year
All sexes
Interventional
Not applicable
Cairo, Egypt
assessment of osteoprotegerin in patients with chronic periodontitis before and after periodontal surgery in gingival crevicular fluid, saliva and gingival tissues.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
an access flap
Time frame: Baseline, 3 months and 6 months
Time frame: Baseline, 3 months and 6 months
Time frame: baseline, 3 months and 6 months
Time frame: baseline, 3 months and 6 months
Time frame: baseline, 3 months and 6 months
Cairo University
Other
Effect of Periodontal Surgery on Osteoprotegerin Levels in Gingival Crevicular Fluid, Saliva and Gingival Tissues.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06893107
Chronic Disease, Chronic Periodontitis
Fujairah, Emirate of Fujairah, United Arab Emirates
View Trial DetailsNCT04274244
Alveolar Bone Loss, Bone Diseases
Valencia, Spain
View Trial DetailsNCT07671456
Aggressive Periodontitis, Chronic Disease
View Trial DetailsNCT03863249
Alveolar Bone Loss, Bone Diseases
Valencia, Spain
View Trial Details